(CXRX) (CXRX) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $0.19 to $0.21
• 50-Day Range: $0.19 to $0.19
• 52-Week Range: $0.19 to $1.80
• Volume: 648,890 shs
• Average Volume: 267,843 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CXRX Stock Analysis - Frequently Asked Questions

How were (CXRX)'s earnings last quarter?

(CXRX) (NASDAQ:CXRX) released its earnings results on Friday, August, 12th. The company reported $1.38 EPS for the quarter, hitting analysts' consensus estimates of $1.38. The business's revenue for the quarter was up 208.1% on a year-over-year basis.

What other stocks do shareholders of (CXRX) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (CXRX) investors own include Intact Financial (IFC), Constellation Software (CSU), Concordia International (CXR), Hudbay Minerals (HBM), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B) and First Quantum Minerals (FM).

Company Calendar

• Last Earnings: 8/12/2016
• Today: 6/05/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CXRX
• CIK: 1642271
• Web: www.concordiarx.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A